Monday, October 20, 2025 10/20/2025

Opioid effects on respiratory-controlling pontine neurons

Award Number: R00DA038069
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/15/2017
PERIOD OF PERFORMANCE END DATE: 01/31/2021

Group Awards By:

View Award Description

Opioid effects on respiratory-controlling pontine neurons - DESCRIPTION (provided by applicant): Death from opioid overdose is primarily due to respiratory depression, yet little is known about the cellular mechanisms of opioids on respiratory-controlling neurons. The long-term goal is to become an independent tenure-track investigator studying the mechanisms responsible for the respiratory depressant effects of opioids. This proposal has been designed to supplement the candidate's background in opioid pharmacology and brain slice electrophysiology and provide the additional knowledge and technical skills in respiratory physiology required to accomplish this goal. Opioids have been shown to suppress respiration through multiple areas of the central respiratory network, including the preBotzinger complex in the medulla and the Kolliker-Fuse (KF) nucleus in the pons. Although opioids have been shown to inhibit preBotzinger neurons, the mechanism of opioid actions in the KF has not been studied and is therefore unknown. The immediate goal of this proposal is to determine how opioids modulate KF neurons to alter respiration. The hypothesis is that opioids hyperpolarize KF neurons to disrupt the respiratory network. This hypothesis will be tested by recording (1) from KF neurons in brain slices and (2) from KF neurons and respiratory nerves in an in situ preparation with intact respiratory network and in vivo respiratory cycle. In Aim 1, extracellular recording from the in situ preparation will identif the respiratory phenotype of KF neurons inhibited by opioids. This new technical skill will be learned through consultation with Drs. Ana Abdala and Julian Paton (University of Bristol) and Mary Heinricher (OHSU) and will be a critical component of the candidate's career development. Given the lack of tolerance to the respiratory depressant effect of opioids, the hypothesis of Aim 2 is that there will be very little tolerance and desensitization of mu opioid receptors on KF neurons. The goal of Aim 3, which will be performed during the independent phase of this award, is to identify the location and function of 5-HT1A receptors that can reverse opioid-induced respiratory depression. A therapeutic strategy such as 5-HT1A agonists that can reverse respiratory depression, but leave analgesia intact would be a significant advance. Mentorship from John Williams, who is a world-renowned electro physiologist and has mentored over 20 scientists to achieve independent careers, will provide continued training in brain slice electrophysiology and development of skills to manage an independent research group. New knowledge in respiratory physiology will be acquired from co-mentor John Bissonnette (OHSU), who has over 30 years of experience in neural control of respiration. The new knowledge, technical skills, continued productivity and practical career guidance will place the candidate in competitive position to become a tenure-track assistant professor studying the respiratory depressant effects of opioids from a cellular and network perspective.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = -$56,126 )
2023	2019	UNIVERSITY OF FLORIDA	1523 UNION RD RM 207	GAINESVILLE	FL	32611	ALACHUA	USA	Drug Use and Addiction Research Programs	000	5	3/13/2023	NON-COMPETING CONTINUATION	-$56,126
														Subtotal = -$56,126

Issue Date FY: 2021 ( Subtotal = -$4,192 )
2021	2019	UNIVERSITY OF FLORIDA	1523 UNION RD RM 207	GAINESVILLE	FL	32611	ALACHUA	USA	Drug Use and Addiction Research Programs	000	5	8/3/2021	NON-COMPETING CONTINUATION	-$4,192
														Subtotal = -$4,192

Issue Date FY: 2019 ( Subtotal = $249,000 )
2019	2019	UNIVERSITY OF FLORIDA	1523 UNION RD RM 207	GAINESVILLE	FL	32611	ALACHUA	USA	Drug Use and Addiction Research Programs	000	5	1/29/2019	NON-COMPETING CONTINUATION	$249,000
														Subtotal = $249,000

Issue Date FY: 2018 ( Subtotal = $249,000 )
2018	2018	UNIVERSITY OF FLORIDA	1523 UNION RD RM 207	GAINESVILLE	FL	32611	ALACHUA	USA	Drug Use and Addiction Research Programs	001	4	4/26/2018	NON-COMPETING CONTINUATION	$24,900
2018	2018	UNIVERSITY OF FLORIDA	1523 UNION RD RM 207	GAINESVILLE	FL	32611	ALACHUA	USA	Drug Use and Addiction Research Programs	000	4	1/24/2018	NON-COMPETING CONTINUATION	$224,100
														Subtotal = $249,000

Issue Date FY: 2017 ( Subtotal = $305,126 )
2017	2017	UNIVERSITY OF FLORIDA	207 GRINTER HALL	GAINESVILLE	FL	32611	ALACHUA	USA	Drug Use and Addiction Research Programs	000	3	2/3/2017	EXTENSION WITH OR WITHOUT FUNDS	$249,000
2017	2017	UNIVERSITY OF FLORIDA	207 GRINTER HALL	GAINESVILLE	FL	32611	ALACHUA	USA	Drug Use and Addiction Research Programs	001	3	3/27/2017	EXTENSION WITH OR WITHOUT FUNDS	$56,126
														Subtotal = $305,126

Grand Total All Awards = $742,809

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Opioid effects on respiratory-controlling pontine neurons

Award Number: R00DA038069

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/15/2017

PERIOD OF PERFORMANCE END DATE: 01/31/2021

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer